Retracted] MicroRNA‑203 inhibits the proliferation and invasion of U251 glioblastoma cells by directly targeting PLD2
Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the PLD2 western blotting data shown in Fig. 3A and the Transwell invasion assay data shown in Fig. 6 were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Molecular Medicine Reports, or were under consideration for publication at around the same time. In view of the fact that certain of these data had already apparently been published previously, the Editor of Molecular Medicine Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 9: 503‑508, 2014; 10.3892/mmr.2013.1814].
Errataetall: |
RetractionOf: Mol Med Rep. 2014 Feb;9(2):503-8. - PMID 24270883 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
Molecular medicine reports - 29(2024), 2 vom: 23. Jan. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Zigui [VerfasserIn] |
---|
Links: |
---|
Themen: |
Glioblastoma |
---|
Anmerkungen: |
Date Revised 14.01.2024 published: Print-Electronic RetractionOf: Mol Med Rep. 2014 Feb;9(2):503-8. - PMID 24270883 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3892/mmr.2023.13154 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366769243 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM366769243 | ||
003 | DE-627 | ||
005 | 20240114235038.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240114s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3892/mmr.2023.13154 |2 doi | |
028 | 5 | 2 | |a pubmed24n1259.xml |
035 | |a (DE-627)NLM366769243 | ||
035 | |a (NLM)38186310 | ||
035 | |a (PII)31 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Zigui |e verfasserin |4 aut | |
245 | 1 | 0 | |a Retracted] MicroRNA‑203 inhibits the proliferation and invasion of U251 glioblastoma cells by directly targeting PLD2 |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 14.01.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a RetractionOf: Mol Med Rep. 2014 Feb;9(2):503-8. - PMID 24270883 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the PLD2 western blotting data shown in Fig. 3A and the Transwell invasion assay data shown in Fig. 6 were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Molecular Medicine Reports, or were under consideration for publication at around the same time. In view of the fact that certain of these data had already apparently been published previously, the Editor of Molecular Medicine Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 9: 503‑508, 2014; 10.3892/mmr.2013.1814] | ||
650 | 4 | |a Retraction of Publication | |
650 | 4 | |a glioblastoma | |
650 | 4 | |a glioma | |
650 | 4 | |a invasion | |
650 | 4 | |a microRNA-203 | |
650 | 4 | |a phospholipase D2 | |
650 | 4 | |a proliferation | |
700 | 1 | |a Li, Dazhi |e verfasserin |4 aut | |
700 | 1 | |a Cheng, Quan |e verfasserin |4 aut | |
700 | 1 | |a Ma, Zhiming |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Bing |e verfasserin |4 aut | |
700 | 1 | |a Peng, Renjun |e verfasserin |4 aut | |
700 | 1 | |a Chen, Rui |e verfasserin |4 aut | |
700 | 1 | |a Cao, Yiqiang |e verfasserin |4 aut | |
700 | 1 | |a Wan, Xin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecular medicine reports |d 2008 |g 29(2024), 2 vom: 23. Jan. |w (DE-627)NLM192195727 |x 1791-3004 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2024 |g number:2 |g day:23 |g month:01 |
856 | 4 | 0 | |u http://dx.doi.org/10.3892/mmr.2023.13154 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 29 |j 2024 |e 2 |b 23 |c 01 |